Creo Medical Group PLC (GB:CREO)
LSE:CREO
Want to see GB:CREO full AI Analyst Report?
Total Valuation
Creo Medical has a market cap or net worth of £59.51M. The enterprise value is 55.14M .
Market Cap£59.51M
Enterprise Value55.14M
Share Statistics
Creo Medical has 449,139,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding449,139,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Creo Medical’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is -38.26%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)-38.26%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee21.58K
Profits Per Employee-62.95K
Employee Count278
Asset Turnover0.10
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Creo Medical is 10.3. Creo Medical’s PEG ratio is -0.07.
PE Ratio10.3
PS Ratio6.81
PB Ratio0.82
Price to Fair Value0.82
Price to FCF-2.20
Price to Operating Cash Flow-2.89
PEG Ratio-0.07
Income Statement
In the last 12 months, Creo Medical had revenue of 6.00M and earned 5.30M in profits. Earnings per share was 0.01.
Revenue6.00M
Gross Profit1.40M
Operating Income-20.70M
Pretax Income-17.50M
Net Income5.30M
EBITDA-19.70M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was -18.90M and capital expenditures 0.00, giving a free cash flow of -18.90M billion.
Operating Cash Flow-18.90M
Free Cash Flow-18.90M
Free Cash Flow per Share-0.04
Dividends & Yields
Creo Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.06
52-Week Price Change-5.36%
50-Day Moving Average12.55
200-Day Moving Average12.33
Relative Strength Index (RSI)50.71
Average Volume (3m)975.48K
Important Dates
Creo Medical upcoming earnings date is Sep 30, 2026, TBA (Not Confirmed).
Last Earnings DateMay 22, 2026
Next Earnings DateSep 30, 2026
Ex-Dividend Date―
Financial Position
Creo Medical as a current ratio of 3.22, with Debt / Equity ratio of 8.20%
Current Ratio3.22
Quick Ratio2.88
Debt to Market Cap0.10
Net Debt to EBITDA0.42
Interest Coverage Ratio-69.00
Taxes
In the past 12 months, Creo Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Creo Medical EV to EBITDA ratio is -1.65, with an EV/FCF ratio of -1.75.
EV to Sales5.42
EV to EBITDA-1.65
EV to Free Cash Flow-1.75
EV to Operating Cash Flow-1.75
Balance Sheet
Creo Medical has £12.40M in cash and marketable securities with £4.10M in debt, giving a net cash position of £8.30M billion.
Cash & Marketable Securities£12.40M
Total Debt£4.10M
Net Cash£8.30M
Net Cash Per Share£0.02
Tangible Book Value Per Share£0.12
Margins
Gross margin is 31.67%, with operating margin of -345.00%, and net profit margin of 88.33%.
Gross Margin31.67%
Operating Margin-345.00%
Pretax Margin-291.67%
Net Profit Margin88.33%
EBITDA Margin-328.33%
EBIT Margin-345.00%
Analyst Forecast
The average price target for Creo Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―